BSE filing, NSE: BHARATCOAL. Summary written from the filing by ALFA Finder's alert engine.
Bharat Coking Coal Ltd: key numbers
- Share price
- ₹30.13
- Market cap
- ₹14,032 Cr
- Revenue (annual)
- ₹13,645 Cr
- Net profit (annual)
- ₹128.3 Cr
- P/E (TTM)
- 233.7×Sector 16.9×
- Promoter holding
- 90.00%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharat Coking Coal Ltd
All →Bharat Coking Coal Management Change
BCCL disclosed transfer of GM (Mining)/HOD Rajiv Chopra to a Coal India subsidiary. Arvind Kumar Sinha assumed the additional charge effective 27 October 2026.
Bharat Coking Coal Investor Presentation: Key Takeaways
H1 FY27 revenue ₹7,999.85 Cr (+16.06% YoY); PAT ₹55.65 Cr vs ₹123.88 Cr. Q2 PAT ₹123.74 Cr vs loss ₹52.99 Cr. FY27 capex target ₹1,000 Cr.
Bharat Coking Coal Q2 FY27 Results: Turns Profitable, Net Profit ₹123.7 Cr
Bharat Coking Coal Ltd reported revenue from operations of ₹4,413 Cr (+39.1% YoY) and net profit of ₹123.7 Cr for Q2 FY27.
- Key figure
- Net profit ₹123.7 Cr
Bharat Coking Coal Other Announcement
Bharat Coking Coal Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Bharat Coking Coal Board Meeting Date
Bharat Coking Coal Limited scheduled a board meeting for October 24, 2026, to consider and approve the standalone financial results for the quarter ended September 30, 2026.
Bharat Coking Coal Legal & Regulatory
BCCL reports a Supreme Court order affirming a lower court decree directing the company to pay Rs.46.20 Crore, arising from a past contractual dispute.
- Value
- ₹46.20 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.